Dihydropyrimidine dehydrogenase polymorphisms in patients with gastrointestinal malignancies and their impact on fluoropyrimidine tolerability: Experience from a single Italian institution
Although this study had a limited sample size, it provides additional information on the prevalence of <i>DPYD</i> polymorphisms in the Italian population and highlights the role of pharmacogenetic testing to prevent severe toxicity.
Authors
- Maria D’Amato (ORCID: https://orcid.org/0000-0002-5906-5701)
- Gennaro Iengo
- Nicholas Massa (ORCID: https://orcid.org/0000-0001-5118-5699)
- Chiara Carlomagno (ORCID: https://orcid.org/0000-0001-5295-3004)
Institutions
- Ospedale Santa Maria (IT)
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.4251/wjgo.v17.i1.96822
- Citations
- 2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57